FCAG
EW icon

First Capital Advisors Group’s Edwards Lifesciences EW Stock Holding History

First Capital Advisors Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$23.1K Buy
+245
New +$21.3K 0.01% 400
2018
Q2 		– Sell
-153
Closed -$7K – 348
2018
Q1 		$7K Buy
+153
New +$6.64K ﹤0.01% 595

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

First Capital Advisors Group's EW Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in Edwards Lifesciences (EW) in Q2 2023: 245 shares worth $23.1K. The stake represents 0.01% of the portfolio and ranks #400 among its holdings. This is a return to the name: First Capital Advisors Group previously reported a position in EW as recently as Q1 2018.

First Capital Advisors Group first reported a position in EW in Q1 2018 and has held it in 2 quarters since. 1,278 funds tracked by Wall St. Rank hold EW as of Q2 2023.

  • First Capital Advisors Group held 245 shares of Edwards Lifesciences worth $23.1K as of Q2 2023.
  • Edwards Lifesciences was a new First Capital Advisors Group position in Q2 2023.
  • Edwards Lifesciences made up 0.01% of First Capital Advisors Group's portfolio in Q2 2023, its #400 holding.
  • First Capital Advisors Group first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 2 quarters since.
  • 1,278 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.